Capital Impact Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-112,567
| Closed | -$422K | – | 86 |
|
|
2024
Q1 | $422K | Sell |
112,567
-33,007
| -23% | -$124K | 0.55% | 75 |
|
|
2023
Q4 | $1.43M | Buy |
145,574
+121,999
| +517% | +$1.2M | 1.88% | 7 |
|
|
2023
Q3 | $197K | Hold |
23,575
| – | – | 0.33% | 100 |
|
|
2023
Q2 | $314K | Hold |
23,575
| – | – | 0.34% | 133 |
|
|
2023
Q1 | $273K | Buy |
23,575
+10,408
| +79% | +$121K | 0.33% | 135 |
|
|
2022
Q4 | $108K | Hold |
13,167
| – | – | 0.11% | 218 |
|
|
2022
Q3 | $140K | Buy |
+13,167
| New | +$140K | 0.14% | 209 |
|
|
2021
Q1 | – | Sell |
-300,000
| Closed | -$7.78M | – | 126 |
|
|
2020
Q4 | $7.78M | Buy |
+300,000
| New | +$7.78M | 1.91% | 10 |
|
|
2015
Q1 | – | Sell |
-26,437
| Closed | -$207K | – | 291 |
|
|
2014
Q4 | $207K | Hold |
26,437
| – | – | 0.1% | 111 |
|
|
2014
Q3 | $130 | Hold |
26,437
| – | – | ﹤0.01% | 183 |
|
|
2014
Q2 | $163K | Buy |
+26,437
| New | +$163K | 0.12% | 156 |
|